SKU Liraglutide

Liraglutide

Liraglutide 3.0 can reduce glycosylated hemoglobin

Other Basic Inorganic Chemical Manufacturing

Price on request

No public price on this one — ask the supplier for a quote.

Details

CAS.NO: 204656-20-2

 

Liraglutide 3.0 can reduce glycosylated hemoglobin, and it has been shown to be beneficial to cardiovascular treatment in typeⅡ diabetic patients with atherosclerotic cardiovascular disease with coronary heart disease, ischemic stroke, and peripheral artery disease. 

 

Insulin Degludec and Liraglutide Transport and Storage Stability

Transportation stability: It is transported in an ice pack to keep it active.

Storage stability: The product can be stored for at least 24 months at -15°C below.

 

Notice and Disclaimer

Pollution should be avoided during operation.

The product should not be used for diagnosis or treatment of animals or humans.

 

If you want to know more about liraglutide in type 1 diabetes, please visit our website.

 

As a biopharmaceutical company, we can offer kinds of Pharmaceutical raw materials for sale, anything you need, please contact us.

 

Welcome to NetU.AI

New to NetU? The code creates your account. Already have one? It logs you in.

Continue with Google
or

By continuing, you agree to our Terms of Service and Privacy Policy.

Sebastian NetU's AI assistant

Hi! I'm Sebastian, NetU's AI assistant. Sign in and ask me anything about NetU — finding buyers and suppliers, growing your network, groups, events, and more.

Sign in to ask Sebastian

Prefer a person? Contact support.